Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

[Chemo- versus radiochemotherapy in stage III non-small-cell lung cancer with poor prognosis: the Conrad Study].

Nieder C.

Strahlenther Onkol. 2014 Jan;190(1):109-10. doi: 10.1007/s00066-013-0490-3. German. No abstract available.

PMID:
24253183
2.

Age and treatment of non-small-cell lung cancer: a database analysis in elderly patients.

Berghmans T, Tragas G, Sculier JP.

Support Care Cancer. 2002 Nov;10(8):619-23. Epub 2002 Sep 4.

PMID:
12436220
3.

Risk associated with bilobectomy after neoadjuvant concurrent chemoradiotherapy for stage IIIA-N2 non-small-cell lung cancer.

Cho JH, Kim J, Kim K, Shim YM, Kim HK, Choi YS.

World J Surg. 2012 May;36(5):1199-205. doi: 10.1007/s00268-012-1472-9.

PMID:
22374538
4.

Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.

Machtay M, Lee JH, Stevenson JP, Shrager JB, Algazy KM, Treat J, Kaiser LR.

J Thorac Cardiovasc Surg. 2004 Jan;127(1):108-13.

5.

Stage III non-small-cell lung cancer: Establishing a benchmark for the proportion of patients suitable for radical treatment.

Al-Shamsi HO, Al Farsi A, Ellis PM.

Clin Lung Cancer. 2014 Jul;15(4):274-80. doi: 10.1016/j.cllc.2014.02.003. Epub 2014 Feb 19.

PMID:
24685356
6.

Combined radiation and chemotherapy for unresectable non-small cell lung carcinoma.

Bleehen NM, Ball D, Belani CP, Bishop J, Douillard JY, Cox JD, Johnson DH, Le Chevalier T, Saunders MI, Shaw E, et al.

Lung Cancer. 1994 Mar;10 Suppl 1:S19-23. Review. No abstract available.

PMID:
8087510
8.

Induction therapy followed by surgery for T3-T4/N0 non-small cell lung cancer: long-term results.

Lococo F, Cesario A, Margaritora S, Dall'Armi V, Nachira D, Cusumano G, Meacci E, Granone P.

Ann Thorac Surg. 2012 May;93(5):1633-40. doi: 10.1016/j.athoracsur.2012.01.109. Epub 2012 Apr 4.

PMID:
22480394
9.

[Therapeutic management of non-small-cell lung carcinoma (NSCLC) of stage III A].

Mornex F.

Rev Pneumol Clin. 2001 Nov;57(5 Pt 2):S29-32. Review. French. No abstract available.

PMID:
11924239
10.

[Non-small-cell bronchial carcinoma--induction--combined with radiochemotherapy--a more certain alternative].

Miletzki A.

Pneumologie. 2007 Oct;61(10):627. German. No abstract available.

PMID:
17922385
11.

[Management of non-small-cell lung carcinoma (NSCLC) of stage III B].

Koukourakis M.

Rev Pneumol Clin. 2001 Nov;57(5 Pt 2):S33-6. Review. French. No abstract available.

PMID:
11924241
12.

Mortality associated with pneumonectomy after induction chemoradiation versus chemotherapy alone in stage IIIA-N2 non-small cell lung cancer.

Van Schil PE.

J Thorac Cardiovasc Surg. 2008 Mar;135(3):718; author reply 718-9. doi: 10.1016/j.jtcvs.2007.10.052. No abstract available.

13.

Combined modality treatment for stage III non-small cell lung cancer.

Bonomi P.

Lung Cancer. 1995 Jun;12 Suppl 2:S41-52. Review.

PMID:
7551949
14.

[Radiochemotherapy in non-small-cell lung cancer].

Swartman B.

Med Klin Intensivmed Notfmed. 2011 Nov;106(3):212-7. doi: 10.1007/s00063-011-0053-2. German. No abstract available.

PMID:
22068757
15.

Phase II trial of a trimodality regimen for stage III non-small-cell lung cancer using chemotherapy as induction treatment with concurrent hyperfractionated chemoradiation with carboplatin and paclitaxel followed by subsequent resection: a single-center study.

Friedel G, Budach W, Dippon J, Spengler W, Eschmann SM, Pfannenberg C, Al-Kamash F, Walles T, Aebert H, Kyriss T, Veit S, Kimmich M, Bamberg M, Kohlhaeufl M, Steger V, Hehr T.

J Clin Oncol. 2010 Feb 20;28(6):942-8. doi: 10.1200/JCO.2008.21.7810. Epub 2010 Jan 25.

PMID:
20100967
16.

Concurrent chemoradiotherapy using cisplatin plus S-1, an oral fluoropyrimidine, followed by surgery for selected patients with stage III non-small cell lung cancer: a single-center feasibility study.

Maruyama R, Hirai F, Ondo K, Kometani T, Hamatake M, Seto T, Sugio K, Ichinose Y.

Surg Today. 2011 Nov;41(11):1492-7. doi: 10.1007/s00595-011-4509-z. Epub 2011 Oct 4.

PMID:
21969151
17.

Non-small cell lung cancer: treatment results at a USAF referral center.

Prestidge BR, Cox RS, Johnson DW.

Mil Med. 1991 Sep;156(9):479-83.

PMID:
1660112
18.

Prognostic value of serial [18F]fluorodeoxyglucose PET-CT uptake in stage III patients with non-small cell lung cancer treated by concurrent chemoradiotherapy.

Zhang HQ, Yu JM, Meng X, Yue JB, Feng R, Ma L.

Eur J Radiol. 2011 Jan;77(1):92-6. doi: 10.1016/j.ejrad.2009.07.023. Epub 2009 Aug 19.

PMID:
19695804
19.

Prognostic significance of weight gain during definitive chemoradiotherapy for locally advanced non-small-cell lung cancer.

Sher DJ, Gielda BT, Liptay MJ, Warren WH, Batus M, Fidler MJ, Garg S, Bonomi P.

Clin Lung Cancer. 2013 Jul;14(4):370-5. doi: 10.1016/j.cllc.2012.10.009. Epub 2012 Dec 20.

PMID:
23260389
20.

Early palliative care in non-small-cell lung cancer.

Ichihara E, Matsuoka J, Kiura K.

N Engl J Med. 2010 Dec 2;363(23):2263; author reply 2264-5. doi: 10.1056/NEJMc1010529#SA1. No abstract available.

PMID:
21121847

Supplemental Content

Support Center